Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452569
Status:
COMPLETED
Last Update Posted:
2019-11-18
First Post:
2007-03-23
Brief Title:
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Celgene
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-01
Start Date Type:
ACTUAL
Primary Completion Date:
2008-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-01-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-03-23
First Submit QC Date:
March 26 2007
Study First Post Date:
2007-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-18
Last Update Post Date Type:
ACTUAL